These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8155771)

  • 1. Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response.
    Lotze MT; Rubin JT; Carty S; Edington H; Ferson P; Landreneau R; Pippin B; Posner M; Rosenfelder D; Watson C
    Hum Gene Ther; 1994 Jan; 5(1):41-55. PubMed ID: 8155771
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.
    Okada H; Pollack IF; Lieberman F; Lunsford LD; Kondziolka D; Schiff D; Attanucci J; Edington H; Chambers W; Kalinski P; Kinzler D; Whiteside T; Elder E; Potter D
    Hum Gene Ther; 2001 Mar; 12(5):575-95. PubMed ID: 11268289
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer.
    Elder EM; Lotze MT; Whiteside TL
    Hum Gene Ther; 1996 Mar; 7(4):479-87. PubMed ID: 8800742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
    Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
    Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.
    Tahara H; Lotze MT; Robbins PD; Storkus WJ; Zitvogel L
    Hum Gene Ther; 1995 Dec; 6(12):1607-24. PubMed ID: 8664385
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
    Okada H; Pollack IF; Lotze MT; Lunsford LD; Kondziolka D; Lieberman F; Schiff D; Attanucci J; Edington H; Chambers W; Robbins P; Baar J; Kinzler D; Whiteside T; Elder E
    Hum Gene Ther; 2000 Mar; 11(4):637-53. PubMed ID: 10724042
    [No Abstract]   [Full Text] [Related]  

  • 7. Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2.
    Pippin BA; Rosenstein M; Jacob WF; Chiang Y; Lotze MT
    Cancer Gene Ther; 1994 Mar; 1(1):35-42. PubMed ID: 7621236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human MDR gene transfer in patients with advanced cancer.
    Hesdorffer C; Antman K; Bank A; Fetell M; Mears G; Begg M
    Hum Gene Ther; 1994 Sep; 5(9):1151-60. PubMed ID: 7833373
    [No Abstract]   [Full Text] [Related]  

  • 9. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
    Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
    Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
    Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
    Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a retroviral vector to study the trafficking patterns of purified ovarian tumor infiltrating lymphocytes (TIL) used in intraperitoneal adoptive immunotherapy of ovarian cancer patients. A pilot study.
    Freedman RS; Platsoucas CD; Deisseroth AB
    Hum Gene Ther; 1996 Jul; 7(11):1351-65. PubMed ID: 8818723
    [No Abstract]   [Full Text] [Related]  

  • 12. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.
    Sobol RE; Royston I; Fakhrai H; Shawler DL; Carson C; Dorigo O; Gjerset R; Gold DP; Koziol J; Mercola D
    Hum Gene Ther; 1995 Feb; 6(2):195-204. PubMed ID: 7734519
    [No Abstract]   [Full Text] [Related]  

  • 13. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
    Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
    Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts and dermal gene therapy: a minireview.
    Krueger GG
    Hum Gene Ther; 2000 Nov; 11(16):2289-96. PubMed ID: 11084688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy and molecular immunology unite to give new life to cancer immunotherapy.
    Ando D
    Mol Ther; 2002 Jun; 5(6):665-7. PubMed ID: 12027549
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gene therapy of malignant tumors].
    Hauses M; Schackert HK
    Zentralbl Chir; 2000; 125 Suppl 1():41-6. PubMed ID: 10929646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical trial to evaluate the safety and biological activity of HIV-IT (TAF) (HIV-1IIIBenv-transduced, autologous fibroblasts) in asymptomatic HIV-1 infected subjects.
    Galpin JE; Casciato DA; Richards SB
    Hum Gene Ther; 1994 Aug; 5(8):997-1017. PubMed ID: 7948149
    [No Abstract]   [Full Text] [Related]  

  • 18. Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis.
    Bessis N; Cottard V; Saidenberg-Kermanach N; Lemeiter D; Fournier C; Boissier MC
    J Gene Med; 2002; 4(3):300-7. PubMed ID: 12112647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.
    Lortal B; Gross F; Peron JM; Pénary M; Berg D; Hennebelle I; Favre G; Couderc B
    Cancer Gene Ther; 2009 Apr; 16(4):329-37. PubMed ID: 18989351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.
    O'Shaughnessy JA; Cowan KH; Wilson W; Bryant G; Goldspiel B; Gress R; Nienhuis AW; Dunbar C; Sorrentino B; Stewart FM
    Hum Gene Ther; 1993 Jun; 4(3):331-54. PubMed ID: 8338880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.